These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31860065)

  • 41. Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.
    Li R; Perneczky R; Yakushev I; Förster S; Kurz A; Drzezga A; Kramer S;
    PLoS One; 2014; 10(4):e0122731. PubMed ID: 25919662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detecting genetic associations with brain imaging phenotypes in Alzheimer's disease via a novel structured SCCA approach.
    Du L; Liu K; Yao X; Risacher SL; Han J; Saykin AJ; Guo L; Shen L
    Med Image Anal; 2020 Apr; 61():101656. PubMed ID: 32062154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
    Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease.
    Kim D; Basile AO; Bang L; Horgusluoglu E; Lee S; Ritchie MD; Saykin AJ; Nho K
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):61. PubMed ID: 28539126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structured Sparse Kernel Learning for Imaging Genetics Based Alzheimer's Disease Diagnosis.
    Peng J; An L; Zhu X; Jin Y; Shen D
    Med Image Comput Comput Assist Interv; 2016 Oct; 9901():70-78. PubMed ID: 28580458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
    Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
    Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
    Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T
    Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A region-of-interest template for three-dimensional stereotactic surface projection images: initial application to the analysis of Alzheimer's disease and mild cognitive impairment.
    Kubota T; Ushijima Y; Okuyama C; Nishimura T
    Nucl Med Commun; 2006 Jan; 27(1):37-44. PubMed ID: 16340722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatially Adaptive Varying Correlation Analysis for Multimodal Neuroimaging Data.
    Li L; Kang J; Lockhart SN; Adams J; Jagust WJ
    IEEE Trans Med Imaging; 2019 Jan; 38(1):113-123. PubMed ID: 30028695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structured Genome-Wide Association Studies with Bayesian Hierarchical Variable Selection.
    Zhao Y; Zhu H; Lu Z; Knickmeyer RC; Zou F
    Genetics; 2019 Jun; 212(2):397-415. PubMed ID: 31010934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward an interpretable Alzheimer's disease diagnostic model with regional abnormality representation via deep learning.
    Lee E; Choi JS; Kim M; Suk HI;
    Neuroimage; 2019 Nov; 202():116113. PubMed ID: 31446125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-dimensional enrichment analysis for mining high-level imaging genetic associations.
    Yao X; Yan J; Kim S; Nho K; Risacher SL; Inlow M; Moore JH; Saykin AJ; Shen L
    Brain Inform; 2017 Mar; 4(1):27-37. PubMed ID: 27747820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-dimensional Enrichment Analysis for Mining High-level Imaging Genetic Associations.
    Yao X; Yan J; Kim S; Nho K; Risacher SL; Inlow M; Moore JH; Saykin AJ; Shen L;
    Brain Inform Health (2015); 2015; 9250():115-124. PubMed ID: 26568986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
    Dyrba M; Grothe MJ; Mohammadi A; Binder H; Kirste T; Teipel SJ;
    J Alzheimers Dis; 2018; 65(3):731-746. PubMed ID: 28697557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.